I applied to R&D LPAR, along with TR11, all other latest groups, and iSeries for Access latest SP.
All PTFs applied, no known issues.

Paul

-----Original Message-----
From: MIDRANGE-L [mailto:midrange-l-bounces@xxxxxxxxxxxx] On Behalf Of Steinmetz, Paul
Sent: Sunday, December 06, 2015 9:25 PM
To: 'Midrange Systems Technical Discussion'
Subject: RE: IBMi V7R1 PTF Package - 15317

Jim,

I applied to a sandbox LPAR with no issues, along with TR11 all latest groups.
I plan to apply to R&D LPAR this week.

Paul

-----Original Message-----
From: MIDRANGE-L [mailto:midrange-l-bounces@xxxxxxxxxxxx] On Behalf Of JWGrant@xxxxxxxxxxxxxxx
Sent: Sunday, December 06, 2015 8:16 PM
To: Midrange Systems Technical Discussion
Subject: IBMi V7R1 PTF Package - 15317

HI ALL:

Has anyone applied V7R1 PTF Package C5317710?

Any issues?

Jim

Jim W Grant
Senior VP, Chief Information Officer
Web: www.pdpgroupinc.com
--
This is the Midrange Systems Technical Discussion (MIDRANGE-L) mailing list To post a message email: MIDRANGE-L@xxxxxxxxxxxx To subscribe, unsubscribe, or change list options,
visit: http://lists.midrange.com/mailman/listinfo/midrange-l
or email: MIDRANGE-L-request@xxxxxxxxxxxx Before posting, please take a moment to review the archives at http://archive.midrange.com/midrange-l.

--
This is the Midrange Systems Technical Discussion (MIDRANGE-L) mailing list To post a message email: MIDRANGE-L@xxxxxxxxxxxx To subscribe, unsubscribe, or change list options,
visit: http://lists.midrange.com/mailman/listinfo/midrange-l
or email: MIDRANGE-L-request@xxxxxxxxxxxx Before posting, please take a moment to review the archives at http://archive.midrange.com/midrange-l.


This thread ...

Follow-Ups:
Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].